Compare CTSO & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTSO | RMTI |
|---|---|---|
| Founded | 1997 | 1994 |
| Country | United States | United States |
| Employees | N/A | 300 |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.2M | 34.0M |
| IPO Year | 2008 | 2022 |
| Metric | CTSO | RMTI |
|---|---|---|
| Price | $0.61 | $0.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $5.38 | $2.00 |
| AVG Volume (30 Days) | 98.7K | ★ 225.9K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.79 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $22,503,908.00 | ★ $69,258,000.00 |
| Revenue This Year | $10.34 | $8.64 |
| Revenue Next Year | $22.41 | $8.44 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 48.53 | N/A |
| 52 Week Low | $0.50 | $0.78 |
| 52 Week High | $1.39 | $2.10 |
| Indicator | CTSO | RMTI |
|---|---|---|
| Relative Strength Index (RSI) | 46.17 | 45.09 |
| Support Level | $0.50 | $0.82 |
| Resistance Level | $0.74 | $1.00 |
| Average True Range (ATR) | 0.05 | 0.05 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 62.45 | 59.96 |
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.